Panretinal Photocoagulation versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes from a Randomized Clinical Trial
Compare patient-centered outcomes in patients with proliferative diabetic retinopathy (PDR) treated with ranibizumab versus panretinal photocoagulation (PRP).
Source: American Journal of Ophthalmology - Category: Opthalmology Authors: Wesley T. Beaulieu, Neil M. Bressler, Michele Melia, Cynthia Owsley, Calvin E. Mein, Jeffrey G. Gross, Lee M. Jampol, Adam R. Glassman, Diabetic Retinopathy Clinical Research Network Source Type: research
More News: Clinical Trials | Diabetes | Endocrinology | Lucentis | Opthalmology | Ranibizumab Injection